Lymphocytic Leukemia, Chronic News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Chronic Lymphocytic Leukemia (CLL) Market -Epidemiology Forecast to 2025 in new research - Medgadget (blog)



Chronic Lymphocytic Leukemia (CLL) Market -Epidemiology Forecast to 2025 in new research 
Medgadget (blog)
?Chronic Lymphocytic Leukemia (CLL) ? Epidemiology Forecast To 2025? provides an overview of the epidemiology trends of Chronic Lymphocytic Leukemia (CLL) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 ...

 


Chronic Lymphocytic Leukaemia: KOL Insight 2017 - PR Newswire (press release)



Chronic Lymphocytic Leukaemia: KOL Insight 2017 
PR Newswire (press release)
Learn how KOLs see the market evolving, and how they expect developers to differentiate their pipeline therapies in KOL Insight: Chronic Lymphocytic Leukaemia (CLL). Twelve US and European KOLs provide their candid insights on seven marketed ...

and more » 


Study: CAR T-Cell Therapy Highly Effective in High-Risk Chronic Lymphocytic Leukemia - AJMC.com Managed Markets Network



Study: CAR T-Cell Therapy Highly Effective in High-Risk Chronic Lymphocytic Leukemia 
AJMC.com Managed Markets Network
CD19 CAR T cells are highly effective in high-risk patients with chronic lymphocytic leukemia (CLL) who have failed to respond to treatment with ibrutinib, a Bruton's tyrosine kinase inhibitor, according to a study by Cameron J. Turtle, MD, and ...

 


Gazyva Wins FDA OK for Untreated Advanced Follicular Lymphoma - Managed Care magazine



Gazyva Wins FDA OK for Untreated Advanced Follicular Lymphoma 
Managed Care magazine
With this approval, obinutuzumab is available in the United States for three different indications across two common types of blood cancer: 1) with the chemotherapy drug chlorambucil to treat chronic lymphocytic leukemia (CLL) in adults who have not ...

and more » 


B-Cell Chronic Lymphocytic Leukemia Market Research Report 2017 - Research of Market



B-Cell Chronic Lymphocytic Leukemia Market Research Report 2017 
Research of Market
B-Cell Chronic Lymphocytic Leukemia-Mechanism of action Insights, 2017?, report provides comprehensive insights of the ongoing therapeutic research and development across B-Cell Chronic Lymphocytic Leukemia. The report provides a complete ...

and more » 


Umbralisib, Ublituximab, Ibrutinib Triplet Reaches 100% Response in CLL - OncLive



OncLive
 
Umbralisib, Ublituximab, Ibrutinib Triplet Reaches 100% Response in CLL 
OncLive
The first known triplet regimen of a CD20 monoclonal antibody plus a PI3K-delta inhibitor and a BTK inhibitor demonstrated clinical activity and tolerability in patients with advanced chronic lymphocytic leukemia (CLL), among other subsets of non ...

and more » 


Roche's (RHHBY) Hemophilia A Drug Receives FDA Approval - Nasdaq



Roche's (RHHBY) Hemophilia A Drug Receives FDA Approval 
Nasdaq
The drug is already approved in combination with chlorambucil to treat chronic lymphocytic leukemia (CLL) in adults who have not had previous CLL treatment. Roche's hematology portfolio consists of approved drugs like MabThera/Rituxan (rituximab), ...

and more » 


Chronic Lymphocytic Leukemia Market : Global Forecast over 2026 - Find Market Research By Abhishek Budholiya (press release) (blog)



Chronic Lymphocytic Leukemia Market : Global Forecast over 2026 
Find Market Research By Abhishek Budholiya (press release) (blog)
Chronic lymphocytic leukemia (CLL) is a blood and bone marrow disease that usually gets adverse slowly. It is one of the most common types of leukemia in adults. Chronic lymphocytic leukemia is a type of cancer in which the bone marrow makes too many ...

and more » 


First Person: Positive change starts with gratitude and unity - ThisWeek Community News



ThisWeek Community News
 
First Person: Positive change starts with gratitude and unity 
ThisWeek Community News
Our funding of the clinical trial of ibrutinib was discovered to be a miracle drug for patients with chronic lymphocytic leukemia, the most common adult leukemia that previously had a very poor prognosis. Once ibrutinib came along, CLL went into ...

and more » 


Cyclin Dependent Kinase 9 - Pipeline Review, H2 2017 - Markets Insider



Cyclin Dependent Kinase 9 - Pipeline Review, H2 2017 
Markets Insider
... Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), Diffuse Large B-Cell Lymphoma, Lung Cancer, Lymphoma, Myelodysplastic Syndrome, Non-Hodgkin Lymphoma, Pancreatic Cancer, Chronic Lymphocytic Leukemia (CLL), Chronic Myelocytic ...

and more »